Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TMC Life Sciences BhdXKLS:0101 61 Earnings per Share (Diluted) is RM0.01 as of Jun. 2026. GuruFocus rates XKLS:0101 with a GF Score™ of 61/100 and a GF Value™ of RM0.57 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 507 Healthcare Providers & Services companies, TMC Life Sciences Bhd ranks worse than 86.19% on this metric.
During the past 12 months, TMC Life Sciences Bhd's average EPS without NRIGrowth Rate was 400.00% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was -23.10% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was -21.20% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was -1.30% per year.
During the past 13 years, TMC Life Sciences Bhd's highest 3-Year average EPS without NRI Growth Rate was 44.20% per year. The lowest was -56.30% per year. And the median was 19.70% per year.
TMC Life Sciences Bhd (XKLS:0101) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
TMC Life Sciences Bhd Earnings per Share (Diluted) Related Terms
TMC Life Sciences Bhd Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for TMC Life Sciences Bhd's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TMC Life Sciences Bhd Earnings per Share (Diluted) Chart
XKLS:0101 vs HCA, THC, DVA: Earnings per Share (Diluted) Comparison
For the Medical Care Facilities subindustry, TMC Life Sciences Bhd's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TMC Life Sciences Bhd PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, TMC Life Sciences Bhd's PE Ratio distribution charts can be found below:
* The bar in red indicates where TMC Life Sciences Bhd's PE Ratio falls into.
TMC Life Sciences Bhd Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
TMC Life Sciences Bhd's Earnings Per Share (Diluted) for the fiscal year that ended in Jun. 2026 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of RM0.01 mean?
TMC Life Sciences Bhd (XKLS:0101) has a Earnings per Share (Diluted) of RM0.01 as of Jun. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on TMC Life Sciences Bhd and its competitors. According to the industry distribution chart, TMC Life Sciences Bhd ranks #437 out of 507 companies in the Healthcare Providers & Services industry, placing it in the top 86.2%.
Is TMC Life Sciences Bhd's Earnings per Share (Diluted) too high?
TMC Life Sciences Bhd's current Earnings per Share (Diluted) is RM0.01. Based on the distribution chart, TMC Life Sciences Bhd ranks #437 out of 507 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, TMC Life Sciences Bhd has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TMC Life Sciences Bhd's Earnings per Share (Diluted) compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, TMC Life Sciences Bhd ranks #437 out of 507 companies for Earnings per Share (Diluted). This places TMC Life Sciences Bhd in the lower half of its industry. The industry median Earnings per Share (Diluted) is 11.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Healthcare Providers & Services company?
The median Earnings per Share (Diluted) among Healthcare Providers & Services companies is 11.00, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on TMC Life Sciences Bhd and its competitors. For the Healthcare Providers & Services industry, the median Earnings per Share (Diluted) is 11.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TMC Life Sciences Bhd's current Earnings per Share (Diluted) is RM0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TMC Life Sciences Bhd stock overvalued right now?
Based on GuruFocus' analysis, TMC Life Sciences Bhd (XKLS:0101) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.57, compared to a current price of RM0.45 — trading 21.1% below its estimated fair value. The current Earnings per Share (Diluted) is RM0.01. TMC Life Sciences Bhd's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For TMC Life Sciences Bhd (XKLS:0101), the current Earnings per Share (Diluted) is RM0.01 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TMC Life Sciences Bhd (XKLS:0101) Overvalued in 2026?
Based on GuruFocus' analysis, TMC Life Sciences Bhd stock appears to be undervalued.
The current stock price of RM0.45 is trading 21.1% below its estimated GF Value™ of RM0.57.
GuruFocus considers TMC Life Sciences Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0101:
Earnings per Share (Diluted): RM0.01
GF Value™: RM0.57 vs. price of RM0.45 (21.1% below fair value)
No single metric tells the full story. See the XKLS:0101 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.
61GF Score
Get the complete analysis for XKLS:0101
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0101 has been successfully added to your 
